Sino Biopharmaceutical Ltd. - ADR
SBHMY
Get informed when a big investor buys or sells
+ FollowMarket Cap$11.56B
Close$
$22.07
69.6% upside
Current Fair Value
69.6% upsideUndervalued by 69.6% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $11.56 Billion |
|---|---|
| Enterprise Value | $21.32 Billion |
| Dividend Yield | $0.26 (1.79%) |
| Earnings per Share | $2.6 |
| Beta | 0.61 |
| Outstanding Shares | 900,067,840 |
Return
| Return on Equity | 7.64% |
|---|---|
| Return on Assets | 3.08% |
| Return on Invested Capital | 12.38% |
Valuation & Multiples
| P/E Ratio | 36.78 |
|---|---|
| PEG | -11.62 |
| Price to Sales | 0.37 |
| Price to Book Ratio | 0.28 |
| Enterprise Value to Revenue | 0.67 |
| Enterprise Value to EBIT | 3.39 |
| Enterprise Value to Net Income | 9 |
| Total Debt to Enterprise | 0.8 |
| Debt to Equity | 0.56 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
March 18, 2026
EPS Estimate
-
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Sino Biopharmaceutical Ltd.
CEO: Ping Tse